Riskpilot← Back to searchSign inGet full accessAlfa Chemicals Nordic ApS
APSActiveCVR 40159320Bredgade 20A, 2. tvWholesale of pharmaceutical and medical goods · NACE 4646Est. 20192 employees
Revenue 2024
DKK 323K
+54% vs 2023
EBITDA margin
10.4%
+66% vs 2023
Equity ratio
39.5%
Financial strength
Net profit 2024
DKK 17K
+58% vs 2023
| Revenue | DKK 323K | +54% |
| EBITDA | DKK 34K | +66% |
| Net profit | DKK 17K | +58% |
| Total assets | DKK 710K | +32% |
| Equity | DKK 280K | +6% |
| Employees | 2 | — |
Legal name
Alfa Chemicals Nordic ApS
CVR number
40159320
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 2019
Share capital
DKK 7.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes alene af Trevor Wesley Mathers.
Company purpose
Selskabets formål er at levere serviceløsninger herunder, men ikke begrænset til, salg af råmaterialer til den industrielle, farmaceutiske og sunheds-sektoren samt enhver anden virksomhed, som ledelsen i selskabet måtte beslutte fra tid til anden.
Address
Bredgade 20A, 2. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 84 | 142 | 262 | 209 | 323 |
| Staff expenses | -0 | -0 | -127 | -189 | -289 |
| EBITDA | 84 | 142 | 135 | 20 | 34 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 84 | 142 | 135 | 20 | 34 |
| Net financials | -15 | -8 | -5 | -7 | -11 |
| Profit before tax | 69 | 133 | 130 | 14 | 23 |
| Tax | 16 | 31 | 30 | 3 | 6 |
| Net profit | 54 | 103 | 100 | 11 | 17 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 374 | 372 | 569 | 536 | 710 |
| Equity | 50 | 152 | 253 | 263 | 280 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 325 | 219 | 316 | 273 | 429 |
| Total debt | 325 | 219 | 316 | 273 | 429 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20202024
Equity ratio
39.5%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20202024
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TW Management | Management | 2019 |
EK Management | Management | 2024 |
| Former (2) | ||
MW Chief Executive Officer | Chief Executive Officer | 2019 – 2019 |
PB Management | Management | 2019 – 2024 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alfa Chemicals Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mark William Walker | Chief Executive Officer | 0 companies |
| Trevor Wesley Mathers | Management | 0 companies |
| Elizabeth Kate Wale | Management | 0 companies |
| Per Bak Gundersen | Management | 0 companies |